Literature DB >> 24627228

Histopathological effects of different therapy strategies in experimental sinus thrombosis.

Erwin Stolz1, Andrea Fett, Carina Wessels.   

Abstract

The optimal treatment for cerebral venous thrombosis is still under debate. The histological consequences of different treatments have not been systematically studied and may be of value in this debate. Thrombosis of the superior sagittal sinus was induced in rats by topical application of ferric chloride. Animals were treated 6 h after operation with subcutaneous injection of 450 IU/kg enoxaparin twice daily (n = 10), with 10 mg recombinant tissue plasminogen activator (rt-PA)/kg (n = 12), and with 6 mg abciximab/kg (n = 10). Eleven animals were treated with saline (controls), and four animals were sham-operated without thrombosis induction. Animals were killed on day 7. Coronal brain slices were stained with hematoxylin-eosin (HE) and against glial fibrillary acidic protein (GFAP), and factor VIII. Histology was quantified in parasagittal and temporal regions of interest. Compared with controls, counts of pyknotic neurons on HE stain were significantly lower in the enoxaparin group. Counts for GFAP-expressing astrocytes were highest in the enoxaparin (p < 0.001) and rt-PA (p < 0.05)-treated groups. Angiogenesis defined as factor VIII-expressing vessels was significantly (p < 0.01) higher in the enoxaparin and significantly lower (p < 0.01) in the rt-PA group compared with controls. In this animal model, we found histological differences related to the different treatments, which cannot be explained by recanalization and its speed alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627228     DOI: 10.1007/s10072-014-1702-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

Review 1.  Astrocytes and brain injury.

Authors:  Yongmei Chen; Raymond A Swanson
Journal:  J Cereb Blood Flow Metab       Date:  2003-02       Impact factor: 6.200

2.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis.

Authors:  K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  A new model of reversible sinus sagittalis superior thrombosis in the rat: magnetic resonance imaging changes.

Authors:  Carina Röttger; Georg Bachmann; Tibo Gerriets; Manfred Kaps; Klaus Kuchelmeister; Walter Schachenmayr; Maureen Walberer; Tiemo Wessels; Erwin Stolz
Journal:  Neurosurgery       Date:  2005-09       Impact factor: 4.654

5.  Reversible MR imaging abnormalities following cerebral venous thrombosis.

Authors:  Carina Röttger; Susan Trittmacher; Tibo Gerriets; Franz Blaes; Manfred Kaps; Erwin Stolz
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

6.  Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.

Authors:  Carina Röttger; Katharina Madlener; Matthias Heil; Tibo Gerriets; Maureen Walberer; Tiemo Wessels; Georg Bachmann; Manfred Kaps; Erwin Stolz
Journal:  Stroke       Date:  2005-02-24       Impact factor: 7.914

Review 7.  Astrocyte intermediate filaments in CNS pathologies and regeneration.

Authors:  Milos Pekny; Marcela Pekna
Journal:  J Pathol       Date:  2004-11       Impact factor: 7.996

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.

Authors:  B S Coller
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Microvascular damage following experimental sinus-vein thrombosis in rats.

Authors:  M R Vosko; J Röther; B Friedl; G Bültemeier; C U A Kloss; G F Hamann
Journal:  Acta Neuropathol       Date:  2003-08-02       Impact factor: 17.088

View more
  1 in total

Review 1.  Inflammation and Severe Cerebral Venous Thrombosis.

Authors:  Shuyuan Hu; Hangil Lee; Haiping Zhao; Yuchuan Ding; Jiangang Duan
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.